Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105
about
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105
description
scientific article published on 11 July 2018
@en
name
Modulation of Circulating Prot ...... Anti-Endoglin Antibody, TRC105
@en
type
label
Modulation of Circulating Prot ...... Anti-Endoglin Antibody, TRC105
@en
prefLabel
Modulation of Circulating Prot ...... Anti-Endoglin Antibody, TRC105
@en
P2093
P1476
Modulation of Circulating Prot ...... Anti-Endoglin Antibody, TRC105
@en
P2093
Andrew B Nixon
Bonne Adams
Charles P Theuer
Christel Rushing
Delia Alvarez
Herbert I Hurwitz
John C Brady
Mark D Starr
Yingmiao Liu
P304
P356
10.1158/1535-7163.MCT-17-0916
P577
2018-07-11T00:00:00Z